As of 2026-05-01, the Fair Value of Rua Life Sciences PLC (RUA.L) is -6.77 GBP. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 20.50 GBP, the upside of Rua Life Sciences PLC is -133.02%.
With the market price of 20.50 GBP and our fair value calculation, Rua Life Sciences PLC (RUA.L) is not a good investment. Investing in RUA.L stocks now will result in a potential loss of 133.02%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2025-09-30 | 5Y Avg | |
| Net income | -2.07 | -2.00 | -1.44 | 0.00 | -0.22 | -1.15 |
| YoY growth | -42.76% | 3.24% | 28.11% | 100.07% | -21,900.00% | -4,362.27% |
| Market Cap (mil) | 12.90 |
| P/E | |
| Forward P/E |
| EPS | -1.35 |
| Avg earnings growth rate | -4,362.27% |
| TTM earnings | -0.85 |